Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Fakiha Siddiqui BDS"'
Autor:
Vanessa Robbin BS, Vinod Bansal MD, Fakiha Siddiqui BDS, Madeline Allen BS, Debra Hoppensteadt-Moorman PhD, Bulent Kantarcioglu MD, Emma Abulencia RN, BSN, CNN, Evangeline Magpoc RN, BSN, Jawed Fareed PhD, Mushabbar Syed MD
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 30 (2024)
In patients with end-stage renal disease (ESRD), heart failure with reduced ejection fraction (HFrEF) is a common comorbidity. Thromboinflammatory processes in both conditions represent complex pathophysiology, demonstrated by dysregulation of thromb
Externí odkaz:
https://doaj.org/article/32da75f348f641509f17585fe25abf3a
Autor:
Fakiha Siddiqui BDS, Alfonso Tafur MD, MS, MBA, Amir Darki MD, Bulent Kantarcioglu MD, Debra Hoppensteadt PhD, Emily Krupa BS, Omer Iqbal MD, Jawed Fareed PhD, Manuel Monreal MD, PhD
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 30 (2024)
Pulmonary embolism (PE) is a heterogenous condition with variable clinical presentations. Thrombin generation potential (TGP) and biomarkers, and blood cellular indices can reflect the underlying pathophysiology and risk stratification of PE. This ca
Externí odkaz:
https://doaj.org/article/59c1ad82c4924d33aa568ed856fbda76
Autor:
Pranathi Karumanchi BS, Divya Sridharan BS, Debra Hoppensteadt PhD, Fakiha Siddiqui BDS, PhD candidate, Jawed Fareed PhD, Vinod Bansal MD
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 30 (2024)
Cardiovascular disease is a prevalent complication in patients with end-stage renal disease (ESRD) on maintenance hemodialysis. In the ESRD patient population, cardiovascular mortality is 20 times higher compared to the general population. The strong
Externí odkaz:
https://doaj.org/article/5a4c8305d0874bd891d731f5712d7421
Autor:
Fakiha Siddiqui BDS, Debra Hoppensteadt PhD, Walter Jeske PhD, Eduardo Ramacciotti MD, PhD, Alfonso Tafur MD, MS, MBA, Jawed Fareed PhD, FAHA
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 30 (2024)
Introduction Andexanet alfa (AA) - zhzo, recombinant coagulation factor Xa, is an approved antidote for oral Xa inhibitors (apixaban and rivaroxaban). Unfractionated heparin (UFH) is commonly used for therapeutic, interventional, and surgical indicat
Externí odkaz:
https://doaj.org/article/b626561e959842a89b3955e3da6842d6
Autor:
Madeline Allen BS, Vinod Bansal MD, Fakiha Siddiqui BDS, Debra Hoppensteadt PhD, Emily Krupa BS, Jawed Fareed PhD, Bulent Kantarcioglu MD
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 29 (2023)
En-stage renal disease (ESRD) is a growing public health problem. The atherosclerotic cardiovascular complications are the leading causes of mortality and morbidity in the ESRD. In this study, we sought to quantify the levels of thrombo-inflammatory
Externí odkaz:
https://doaj.org/article/1484f6f45c4d4224bb6a176386ef2c66
Autor:
Alexander O’Hara BS, Jacob Pozin BS, Amir Darki MD, MSc, Fakiha Siddiqui BDS, Debra Hoppensteadt PhD, Jeanine Walenga PhD, Jawed Fareed PhD, Bulent Kantarcioglu MD
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 29 (2023)
Type I and type II diabetes are closely associated with a pro-inflammatory state and to a pro-thrombotic state. The role of glycemic control in pulmonary embolism (PE) is poorly understood and requires additional investigation. The aim of this study
Externí odkaz:
https://doaj.org/article/b6d3e73ab61346bcbbc66709c9086fdb
Autor:
Guy Olson BS, Walter Jeske PhD, Omer Iqbal MD, Emily Krupa BS, Amber Farooqui MD, Fakiha Siddiqui BDS, Debra Hoppensteadt PhD, Ahmed Kouta PhD, Jawed Fareed PhD
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 29 (2023)
Introduction: Bovine and ovine mucosa represent alternate anticoagulants to porcine mucosa for production of unfractionated heparin (UFH). Standardized heparins from various sources can be blended and potency adjusted, blended heparins exhibit compar
Externí odkaz:
https://doaj.org/article/a22e14aa5cf148389f9dbf9a742d529d
Autor:
Yevgeniy Brailovsky DO, MSc, Vladimir Lakhter DO, Joshua Newman MD, Sorcha Allen MBBCh, Ahmed Elkaryoni MD, Parth Desai MD, Dalila Masic PharmD, Carlos F. Bechara MD, Emily Bontekoe BS, Debra Hoppensteadt PhD, John J. Lopez MD, Fakiha Siddiqui BDS, Omer Iqbal PhD, Jawed Fareed PhD, Amir Darki, MD, MSc
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 29 (2023)
Background Acute pulmonary embolism (PE) is a heterogeneous disease process with variable presentation and outcomes. The endogenous fibrinolytic system is a complex framework of regulatory pathways that maintains homeostasis by dissolving overabundan
Externí odkaz:
https://doaj.org/article/7f1e6de3abd5418699902e753ad986f7
Autor:
Bulent Kantarcioglu MD, Siddharth Mehrotra, Charulatha Papineni PharmB, MS, Fakiha Siddiqui BDS, Ahmed Kouta PharmD, PhD, Debra Hoppensteadt PhD, Vinod Bansal MD, Amir Darki MD, David H. Van Thiel MD, Jawed Fareed PhD
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 28 (2022)
Endogenous glycosaminoglycans (GAGs) with a similar structure to heparin are widely distributed in various tissues. A fluorescence probe, namely Heparin Red, can detect polyanionic GAGs in plasma samples. The purpose of this study is to measure endog
Externí odkaz:
https://doaj.org/article/e36e1bb2ff0c446b976d35889f671e9a
Autor:
Bulent Kantarcioglu MD, Amir Darki MD, MSc, Fakiha Siddiqui BDS, Emily Krupa BS, Mehmet Vural MD, Murat Kacmaz MD, Debra Hoppensteadt PhD, Omer Iqbal MD, Walter Jeske PhD, Jeanine Walenga PhD, Cafer Adiguzel MD, Jawed Fareed PhD
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 28 (2022)
Introduction In this study, we profiled the levels of blood cellular indices, endogenous glycosaminoglycans (GAGs) and inflammatory biomarkers in a cohort comprised of pulmonary embolism (PE) patients, to determine their inter-relationships. Identifi
Externí odkaz:
https://doaj.org/article/110980c3dd7e456e97b9d9aa585a6b9c